Research summary, original research, 2017

Operator Pelvic Radiation Exposure During Percutaneous Coronary Procedures

Sciahbasi A, Piccaluga E, Sarandrea A, Nucci G, Caretto N, Rigattieri S, et al.. The Journal of invasive cardiology. 2017

Read the original paper

In plain language

In one interventional cardiologist's coronary procedures, dosimeter readings at the pelvis were about seven times higher than at the chest, regardless of radial or femoral access. This is a dose measurement, not a health outcome.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Interventional cardiologists
Size
n = 138 procedures
Summary based on
the abstract

What it found

  • Operator pelvic dose was significantly higher than thorax dose during percutaneous coronary procedures.

    Key figures: 40.1 μSv (IQR 22.7-76.3) pelvic vs 5.6 μSv (IQR 1.5-12) thorax; P<.001

  • The pelvic excess persisted after normalization by dose-area product.

    Key figures: 2.98 μSv/Gy•cm² pelvic vs 0.33 μSv/Gy•cm² thorax; P<.001

  • Pelvic dose did not differ by vascular access site (right radial, left radial, femoral).

    Key figures: 42 μSv vs 39 μSv vs 40 μSv; P=.43

  • Procedures had median fluoroscopy time 226 s and median dose-area product (DAP) 15.3 Gy•cm².

    Key figures: 226 sec (IQR 117-407); 15.3 Gy•cm² (IQR 9.3-27.8)

Limits to keep in mind

Single operator at a single center with pelvic dosimetry in only 138 of 2028 procedures, and few femoral cases (15); the abstract does not state whether dosimeters were worn over or under protective garments.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.